Health Condition 1: F845- Aspergers syndrome Health Condition 2: F840- Autistic disorder Health Condition 3: R620- Delayed milestone in childhood Health Condition 4: F70- Mild intellectual disabilities Health Condition 5: F71- Moderate intellectual disabilities Health Condition 6: R625- Other and unspecified lack of expected normal physiological development in childhood Health Condition 7: F849- Pervasive developmental disorder,unspecified Health Condition 8: F89- Unspecified disorder of psychol
Conditions
Interventions
Intervention1: Experimental (6 months): For 6 months the particpant will use the AI-based CognitiveBotics
platform for a Minimum of four sessions per week, each lasting
30-minutes, alongside their reg
Sponsors
Cognitivebotics Technologies Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children with a Mental Age of 2 to 6 years or a chronological age of 2 to 8 years. 2. Children with mild to moderate levels of developmental delay or intellectual disability and Autism Spectrum Disorder and are currently undergoing conventional therapy. 3. Children who are able to engage in short duration digital activities with parental guidance. 4. Parents who have access to touch based laptops, tablets, or smartphones with a good internet connection. 5. Parents or caregivers must provide informed consent and be willing to support the child s participation.
Exclusion criteria
Exclusion criteria: 1. Children with severe cognitive impairment and/or co-occurring neurological disorders. 2. Presence of comorbid conditions that might impact cognitive or physical functioning. 3. Children with sensory impairments that prevent them from using the AI-based learning platform (e.g., blindness, severe hearing loss). 4. Children with the diagnosis of ADHD. 5. Parents or caregivers who wouldn t consent to be part of the study. 6. Parents or caregivers unwilling to comply with therapy schedules or follow-up assessments. 7. Parents who do not meet the requirements for the device specifications to be part of the study. 8. Children who are currently enrolled in an ongoing clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that children in the Experimental group will show measurable improvements in cognitive, social, and communication skills compared to the control group. The AI-based learning platform is anticipated to promote skill acquisition in children who can engage with structured digital learning experiences.Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr Rajvir Rao
Cognitivebotics Technologies Private Limited
Outcome results
None listed